Alzprotect
Manufacturing · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
85 Rue Nelson Mandela, Loos, Hauts-de-Fr...Phone Number
+33 972649757Website
www.alzprotect.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Alzprotect
Alzprotect is a pioneering biopharmaceutical company focused on developing innovative therapeutic solutions for neurodegenerative diseases, including Alzheimer's disease and Progressive Supranuclear Palsy (PSP). The company aims to halt neurodegeneration and restore brain functions through its novel AZP2006 molecule, which targets key markers of neurodegeneration such as Amyloid beta peptide and Tau protein. Alzprotect's intended clients include patients suffering from neurodegenerative conditions and the broader medical community involved in their treatment. With a commitment to research and development, Alzprotect is at the forefront of addressing the unmet needs in neurodegenerative disease therapies.Explore more
Alzprotect Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alzprotect your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Alzprotect has recently received funding, and reach out quickly before it becomes old news!
Check out if Alzprotect is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Alzprotect has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Alzprotect
Product Launch: Get notified when Alzprotect launches new products
Earning: See what the market has to say on Alzprotect recently announced quarterly report
Click to see if Alzprotect had a recent Job posting/layoffs
Alzprotect, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Alzprotect as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Alzprotect is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alzprotect is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alzprotect.
Alzprotect Tech Stack
A closer look at the technologies used by Alzprotect
See more technologies
Alzprotect News & Media
Positive Feedback From the EMA and FDA on Alzprotect's Phase 2b/3 Development Strategy for PSP
LILLE, France--(BUSINESS WIRE)--ALZPROTECT is thrilled to announce that it has received favorable feedback from both the American (FDA) and European (EMA) authorities regarding the regulatory path for advancing the clinical development of Ezeprogind/AZP2006 for patients with PSP. This significant milestone follows the already very promising results of the phase 2a study in PSP and marks a decisive advancement. It will provide a clear path for the further development of Ezeprogind/AZP2006 withinAlzprotect Awarded a Grant from The Michael J. Fox Foundation to Advance Small Molecule Parkinson’s Disease Program
Alzprotect, a French biopharmaceutical company has been awarded a USD $338,000 grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) LOOS, HAUTS DE FRANCE, FRANCE, June 1, 2022 /EINPresswire.com/ -- Alzprotect, a French …Alzprotect strengthens its Board of Directors with the arrival of Dr. John Tchelingerian
ALZPROTECT announced Dr. John Tchelingerian has joined the Board of Directors of Alzprotect.Alzprotect et l’Hôpital Fondation Rothschild annoncent la signature d’une collaboration contre la neurodégénération
Alzprotect et l’Hôpital Fondation Rothschild annoncent la signature d’une collaboration dans le cadre d’un test clinique de phase 2 pour le traitement de la PSP LILLE, HDF, FRANCE, May 11, 2021 /EINPresswire.com/ -- Alzprotect et l’Hôpital Fondation …
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alzprotect
Sign Up For FreeTo access detailed company insights
Alzprotect is a pioneering biopharmaceutical company focused on developing innovative therapeutic solutions for neurodegenerative diseases, including Alzheimer's disease and Progressive Supranuclear Palsy (PSP). The company aims to halt neurodegeneration and restore brain functions through its novel AZP2006 molecule, which targets key markers of ne... Read More
